Cerdulatinib for the treatment of B-cell malignancies

• 收藏
• 分享

专利权人:

Portola Pharmaceuticals; Inc.

发明人:

Pandey, Anjali,Coffey, Gregory,Leeds, Janet

申请号：

AU2016270658

公开号：

AU2016270658A1

申请日:

2016.05.27

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Provided herein are compositions and methods for treating a relapsed or refractory hematologic cancer in a human patient in need thereof. The methods entail administering to the patient a daily dose of about 10 mg to about 75 mg of cerdulatinib or a pharmaceutically acceptable salt thereof, wherein the patients suffer one or more of a B-cell malignancy, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL) or other transformed FL and/or have relapsed or not responded to a prior chemotherapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/